Suchergebnisse - "Busaidy, Naifa L"

PubPharm (142)

1

Checkpoint Inhibition in Addition to Dabrafenib/Trametinib for BRAFV600E-Mutated Anaplastic Thyroid Carcinoma

enthalten in: Thyroid : official journal of the American Thyroid Association | 2024

von Hamidi, S. | Iyer, P. | Dadu, R. | +6

2

Pediatric Medullary Thyroid Carcinoma : Clinical Presentations and Long-term Outcomes in 144 Patients Over Six Decades

enthalten in: The Journal of clinical endocrinology and metabolism | 2024

von Hensley, S. | Hu, M. | Bassett, R. | +7

3

Decreasing utilization for postoperative radiation therapy in locoregionally advanced medullary thyroid cancer

enthalten in: Head & neck | 2024

von Maniakas, A. | Sullivan, A. | Hu, M. | +17

4

Neoadjuvant Selective RET Inhibitor for Medullary Thyroid Cancer : A Case Series

enthalten in: Thyroid : official journal of the American Thyroid Association | 2023

von Contrera, K. | Gule-Monroe, M. | Hu, M. | +13

5

Review article : new treatments for advanced differentiated thyroid cancers and potential mechanisms of drug resistance

enthalten in: Frontiers in endocrinology | 2023

von Hamidi, S. | Hofmann, M. | Iyer, P. | +4

6

Molecular mechanisms of resistance to kinase inhibitors and redifferentiation in thyroid cancers

enthalten in: Endocrine-related cancer | 2022

von Hofmann, M. | Kunnimalaiyaan, M. | Wang, J. | +5

7

Redifferentiation Therapy-Returning to Our Roots in a Post-Kinase Inhibitor World

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von Cabanillas, M. | Busaidy, N. | Sherman, S.

CommentOn: Clin Cancer Res. 2022 Oct 3;28(19):4194-4202. - PMID 35594174

8

Dabrafenib Versus Dabrafenib + Trametinib in BRAF-Mutated Radioactive Iodine Refractory Differentiated Thyroid Cancer : Results of a Randomized, Phase 2, Open-Label Multicenter Trial

enthalten in: Thyroid : official journal of the American Thyroid Association | 2022

von Busaidy, N. | Konda, B. | Wei, L. | +12

9

Impact of Somatic Mutations on Survival Outcomes in Patients With Anaplastic Thyroid Carcinoma

enthalten in: JCO precision oncology | 2022

von Wang, J. | Montierth, M. | Xu, L. | +16

10

Larotrectinib Before Initial Radioactive Iodine Therapy in Pediatric TRK Fusion-Positive Papillary Thyroid Carcinoma : Time to Reconsider the Treatment Paradigm for Distantly Metastatic Disease?

enthalten in: JCO precision oncology | 2022

von Waguespack, S. | Tewari, S. | Busaidy, N. | +1

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[15]